Other
1 - 9 of
9 Results
Sort Results:
Article:
Xeljanz (ZEL-jans, tofacitinib), a new ORAL tablet for moderate to severe rheumatoid arthritis in adults
September 2014
Guideline:
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
July 2012